The oncology molecular diagnostics market is booming, with a CAGR exceeding 12% driven by personalized medicine and technological advancements like NGS. Explore market size, segmentation (by cancer type, technology, and region), key players (Agilent, Danaher, QIAGEN), and future growth projections in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.